Somnath Roy
Overview
Explore the profile of Somnath Roy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
324
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar D, Roy S, Babu A, Pandey A
J Basic Microbiol
. 2025 Feb;
:e70003.
PMID: 40007229
Pests and diseases have a significant impact on crop health and yields, posing a serious threat to global agriculture. Effective management strategies, such as integrated pest management (IPM), including crop...
2.
Roy S, Coccolo M, Sanjuan M
Phys Rev E
. 2025 Feb;
111(1-1):014225.
PMID: 39972880
We investigate how a constant time delay influences a parametric autoresonant system. This is a nonlinear system driven by a parametrically chirped force with a negative delay feedback that maintains...
3.
Basha F, Sar P, Bhowmick P, Mahato A, Bisht D, Iquebal M, et al.
Mol Genet Genomics
. 2024 Dec;
299(1):112.
PMID: 39625651
Early seedling vigour (ESV) is a key trait that enhances early establishment, stress tolerance, and grain yield in rice, especially in direct-seeded rice (DSR) systems. The aus varietal groups is...
4.
Chacon R, Palmero F, Martinez P, Roy S
Phys Rev E
. 2024 Nov;
110(4-1):044203.
PMID: 39562852
An energy-based theory of autoresonance in driven dissipative chains of coupled generic oscillators is discussed on the basis of a variational principle concerning the energy functional. The theory is applied...
5.
Tansir G, Sharma A, Biswas B, Sah S, Roy S, Deo S, et al.
Front Oncol
. 2024 Nov;
14:1382856.
PMID: 39497712
Background: The medical management of DT comprises tyrosine kinase inhibitors (TKIs), hormonal agents, anti-inflammatory drugs with the recently approved gamma secretase inhibitor nirogacestat being the current standard of care. Real-world...
6.
Pandey A, Yadav S, Samota M, Sharma H, Roy S
Pestic Biochem Physiol
. 2024 Oct;
205:106115.
PMID: 39477576
The gray blight incited by Pestalotiopsis and allied genera is a prevalent disease affecting tea cultivation, and managing it with Trichoderma spp. is an alternative to synthetic fungicides. Plants modify...
7.
Roy S, Raychaudhuri S, Biswas B, Dabkara D, Bhattacherjee A, Ganguly S, et al.
Ecancermedicalscience
. 2024 Oct;
18:1775.
PMID: 39430082
Background: Non-clear-cell renal cell carcinoma (nccRCC) refers to a rare diverse heterogeneous group of tumours; usually treated with immune check point inhibitors and or tyrosine kinase inhibitors (TKIs). Prospective large-scale...
8.
Ray P, Kumar P, Roy S, Das A, Das P
Biomicrofluidics
. 2024 Sep;
18(5):051505.
PMID: 39345268
The scarcity of blood for transfusion purposes has been widely acknowledged. Surgical therapeutic processes, war zones, and post-disaster treatments demand a huge amount of blood. Modern-day laboratories also require blood...
9.
Roy S, Saha D, Ahmed R, Sharma N, Mahanta Sr P
Cureus
. 2024 Aug;
16(7):e63690.
PMID: 39092325
Introduction Malaria is the most common parasitic disease affecting humans. Haematological alterations in malaria are expected, and these changes play a significant role in fatal complications. The present study aims...
10.
Roy S, Biswas B, Dabkara D, Ganguly S, Ghosh J, Bhattacharjee A, et al.
Cureus
. 2024 Jun;
16(6):e61978.
PMID: 38855498
Background Treatment of metastatic renal cell cancer (mRCC) has revolutionized with the introduction of anti-VEGF tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs). There is limited data in the...